Results 71 to 80 of about 7,925 (135)

Biomarker potential of vanin-1-derived pantothenic acid in diabetes and its associated cardiovascular complications. [PDF]

Sci Rep
Shoura NK, Elbatreek MH, Mousa MM, El-Bassossy HM, El-Azzazy OY.   +4 more
europepmc   +1 more source

The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis. [PDF]

Acta Derm Venereol
Wang S, Vaz R, Lysell J, Eisfeldt J, Sahlén P, Asad S, Wahlgren CF, Nordenskjöld M, Bradley M, Tapia-Paez I.   +9 more
europepmc   +1 more source

Emerging therapeutic strategies for cystinosis. [PDF]

Front Pediatr
Goodyer P, Torban E.
europepmc   +1 more source

Long-term outcomes in nephropathic cystinosis: a review. [PDF]

Pediatr Nephrol
Chang HE, Hossain MS, Song C, Surampudi N, Nesterova G, Gahl WA.   +5 more
europepmc   +1 more source

Optimizing Low Crude Protein Diets with Coated Cysteamine Hydrochloride and Exogenous Alkaline Protease Supplementation in Broiler Chickens. [PDF]

Vet Sci
Siddique HAB, Khan EU, Muneeb M, Naveed S, Soumeh EA, Ahmad S, Alhotan RA, Alharthi AS, Abudabos AE.   +8 more
europepmc   +1 more source

Synthesis of carbon quantum dots based on hemp leaves and cysteamine for latent fingerprint detection and their potential therapeutic anticancer application. [PDF]

Nanoscale Adv
Kampangta R, Saenchoopa A, Obrom W, Thet Tun WS, Muanprasat C, Maeda K, Suwannapaporn P, Suppaso C, Seemakram W, Boonlue S, Kulchat S.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cysteamine and cystamine

1987
Publisher Summary This chapter discusses about cysteamine and cystamine. Cysteamine (2-aminoethanethiol) is formed in mammalian tissues by the enzymatic hydrolysis of pantetheine, and has the role in the biosynthesis of hypotaurine. Cysteamine has been used therapeutically to treat cystinosis and sickle cell anemia, and has been used as a protective ...
M W, Duffel, D J, Logan, D M, Ziegler
openaire   +2 more sources

Treatment of cystinosis with cysteamine

The Journal of Pediatrics, 1979
C v s T I N 0 S I S is a recessively inherited metabolic disorder characterized by an accumulation of nonprotein cystine within the lysosomes. 1 ! n the juvenile nephropathic form, the disease presents with tubular renal dysfunction and progressive glomerular damage, leading to end-stage renal failure and eventual death.
E P, Girardin, M S, DeWolfe, J F, Crocker   +2 more
openaire   +2 more sources

Cysteamine Toxicity in Patients with Cystinosis

The Journal of Pediatrics, 2011
To report new adverse effects of cysteamine.Detailed clinical information was obtained from the patients' physicians.New adverse events were reported in 8 of 550 patients with cystinosis treated with cysteamine in Europe during the last 5 years. Detailed clinical information was not available for 2 of these patients, 1 of whom died from cerebral ...
Besouw, M.T., Bowker, R., Dutertre, J.P., Emma, F., Gahl, W.A., Greco, M., Lilien, M.R., McKiernan, J., Nobili, F., Schneider, J.A., Skovby, F., van den Heuvel, L.P., van den Heuvel, L.P., van 't Hoff, W.G., Levtchenko, E.N.   +14 more
openaire   +5 more sources

Metal Content of Cysteamine Oxygenase

European Journal of Biochemistry, 1968
Cysteamine oxygenase has been analysed for the presence of metals, by spectrographic analysis, and X‐ray fluorescence. Iron, copper, and zinc have been found in the enzyme in the quantity accounting for 1 atom of each metal per molecule of enzyme.Passage of the enzyme through a chelating resin column did not appreciable change the specific activity but
D, Cavallini, S, Duprè, R, Scandurra, M T, Graziani, F, Cotta-Rasusino   +4 more
openaire   +2 more sources